TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Funding Opportunities: RFA Available: Teams For Molecular Target Assessment November 26, 1999
TCL Archive “Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising. May 18, 2007
TCL Archive In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored October 26, 1990